Insider Selling: Astera Labs (NASDAQ:ALAB) Director Sells 2,500 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Jack Lazar sold 2,500 shares of the stock in a transaction on Monday, March 16th. The stock was sold at an average price of $130.00, for a total transaction of $325,000.00. Following the completion of the sale, the director directly owned 84,851 shares of the company’s stock, valued at approximately $11,030,630. This trade represents a 2.86% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Astera Labs Trading Up 0.1%

Shares of ALAB traded up $0.09 during trading hours on Tuesday, reaching $127.57. 5,935,822 shares of the stock traded hands, compared to its average volume of 5,365,965. The company has a market cap of $21.71 billion, a P/E ratio of 104.57, a price-to-earnings-growth ratio of 2.37 and a beta of 1.75. The company’s 50-day moving average price is $147.10 and its two-hundred day moving average price is $167.60. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The business had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. During the same period last year, the firm earned $0.37 earnings per share. The business’s quarterly revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Institutional Investors Weigh In On Astera Labs

Several large investors have recently bought and sold shares of ALAB. Vanguard Group Inc. lifted its position in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the last quarter. State Street Corp increased its holdings in shares of Astera Labs by 32.5% in the 4th quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the last quarter. Geode Capital Management LLC increased its holdings in shares of Astera Labs by 4.5% in the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock worth $403,598,000 after buying an additional 104,935 shares during the last quarter. Fred Alger Management LLC raised its position in shares of Astera Labs by 25.5% during the 4th quarter. Fred Alger Management LLC now owns 1,934,688 shares of the company’s stock valued at $321,855,000 after buying an additional 393,250 shares in the last quarter. Finally, Morgan Stanley raised its position in shares of Astera Labs by 33.0% during the 4th quarter. Morgan Stanley now owns 1,934,467 shares of the company’s stock valued at $321,818,000 after buying an additional 480,009 shares in the last quarter. Institutional investors own 60.47% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on ALAB shares. Morgan Stanley reissued an “overweight” rating and issued a $210.00 price target on shares of Astera Labs in a report on Wednesday, December 3rd. Weiss Ratings lowered shares of Astera Labs from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, February 23rd. Raymond James Financial assumed coverage on shares of Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, December 3rd. Finally, Citigroup cut their target price on shares of Astera Labs from $275.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Fifteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $202.22.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.